BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saiz-Rodríguez M, Almenara S, Navares-Gómez M, Ochoa D, Román M, Zubiaur P, Koller D, Santos M, Mejía G, Borobia AM, Rodríguez-Antona C, Abad-Santos F. Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates. Biomedicines 2020;8:E94. [PMID: 32331352 DOI: 10.3390/biomedicines8040094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Pinto-merino Á, Labrador J, Zubiaur P, Alcaraz R, Herrero MJ, Montesinos P, Abad-santos F, Saiz-rodríguez M. Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. Pharmaceutics 2022;14:559. [DOI: 10.3390/pharmaceutics14030559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Buzea CA, Dima L, Correll CU, Manu P. Drug-drug interactions involving antipsychotics and antihypertensives. Expert Opin Drug Metab Toxicol 2022;18:285-98. [PMID: 35658798 DOI: 10.1080/17425255.2022.2086121] [Reference Citation Analysis]
3 Magarbeh L, Gorbovskaya I, Le Foll B, Jhirad R, Müller DJ. Reviewing pharmacogenetics to advance precision medicine for opioids. Biomed Pharmacother 2021;142:112060. [PMID: 34523422 DOI: 10.1016/j.biopha.2021.112060] [Reference Citation Analysis]
4 Déri M, Szakál-Tóth Z, Fekete F, Mangó K, Incze E, Minus A, Merkely B, Sax B, Monostory K. CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients. Sci Rep 2021;11:21389. [PMID: 34725418 DOI: 10.1038/s41598-021-00942-y] [Reference Citation Analysis]
5 García-García I, Borobia AM. Current approaches and future strategies for the implementation of pharmacogenomics in the clinical use of azole antifungal drugs. Expert Opin Drug Metab Toxicol 2021;17:509-14. [PMID: 33622115 DOI: 10.1080/17425255.2021.1890715] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liang H, Zhang X, Ma Z, Sun Y, Shu C, Zhu Y, Zhang Y, Hu S, Fu X, Liu L. Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension. Pharmgenomics Pers Med 2021;14:189-97. [PMID: 33564260 DOI: 10.2147/PGPM.S291277] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Williams ML, Kannankeril PJ, Breeyear JH, Edwards TL, Van Driest SL, Choi L. Effect of CYP3A5 and CYP3A4 Genetic Variants on Fentanyl Pharmacokinetics in a Pediatric Population. Clin Pharmacol Ther 2021. [PMID: 34877660 DOI: 10.1002/cpt.2506] [Reference Citation Analysis]
8 Serras AS, Rodrigues JS, Cipriano M, Rodrigues AV, Oliveira NG, Miranda JP. A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies. Front Cell Dev Biol 2021;9:626805. [PMID: 33732695 DOI: 10.3389/fcell.2021.626805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chan SW, Chu TTW, Ho CS, Kong APS, Tomlinson B, Zeng W. Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients. Front Med (Lausanne) 2021;8:683498. [PMID: 34568359 DOI: 10.3389/fmed.2021.683498] [Reference Citation Analysis]
10 Forster J, Duis J, Butler MG. Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome. Genes (Basel) 2021;12:152. [PMID: 33498922 DOI: 10.3390/genes12020152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lim SYM, Alshagga MA, Alshawsh MA, Ong CE, Pan Y. In vitro effects of 95% khat ethanol extract (KEE) on human recombinant cytochrome P450 (CYP)1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2 and CYP3A5. Drug Metab Pers Ther 2021;37:55-67. [PMID: 35146975 DOI: 10.1515/dmpt-2021-1000196] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jonsson-Schmunk K, Ghose R, Croyle MA. Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A. Expert Rev Vaccines 2021;20:623-34. [PMID: 33666138 DOI: 10.1080/14760584.2021.1899818] [Reference Citation Analysis]
13 Iannaccone T, Sellitto C, Manzo V, Colucci F, Giudice V, Stefanelli B, Iuliano A, Corrivetti G, Filippelli A. Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters. Pharmaceuticals (Basel) 2021;14:204. [PMID: 33804537 DOI: 10.3390/ph14030204] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ramos KN, Gregornik D, Ramos KS. Pharmacogenomics insights into precision pediatric oncology. Curr Opin Pediatr 2021;33:564-9. [PMID: 34561358 DOI: 10.1097/MOP.0000000000001065] [Reference Citation Analysis]
15 Zubiaur P, Soria-Chacartegui P, Koller D, Navares-Gómez M, Ochoa D, Almenara S, Saiz-Rodríguez M, Mejía-Abril G, Villapalos-García G, Román M, Martín-Vílchez S, Abad-Santos F. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers. Biomed Pharmacother 2021;133:111087. [PMID: 33378980 DOI: 10.1016/j.biopha.2020.111087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mulder TAM, van Eerden RAG, de With M, Elens L, Hesselink DA, Matic M, Bins S, Mathijssen RHJ, van Schaik RHN. CYP3A422 Genotyping in Clinical Practice: Ready for Implementation? Front Genet 2021;12:711943. [PMID: 34306041 DOI: 10.3389/fgene.2021.711943] [Reference Citation Analysis]
17 Othman H, da Rocha JEB, Hazelhurst S. Single Nucleotide Polymorphism Induces Divergent Dynamic Patterns in CYP3A5: A Microsecond Scale Biomolecular Simulation of Variants Identified in Sub-Saharan African Populations. Int J Mol Sci 2021;22:7786. [PMID: 34360551 DOI: 10.3390/ijms22157786] [Reference Citation Analysis]
18 Habtemariam HD, Guchelaar H. The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression. Pharmaceuticals 2022;15:252. [DOI: 10.3390/ph15020252] [Reference Citation Analysis]
19 El-Sayed NNE, Al-Otaibi TM, Alonazi M, Masand VH, Barakat A, Almarhoon ZM, Ben Bacha A. Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SRA, Molecular Docking, and ADMET Analyses. Molecules 2021;26:3121. [PMID: 34071141 DOI: 10.3390/molecules26113121] [Reference Citation Analysis]
20 Divsalar B, Kalantari T, Mohebbi S, Bahmanimehr A, Dehbidi GR, Borhani-haghighi A. CYP3A4⁎22 gene polymorphism and risk of ischemic stroke in south Iran population: A case control study. Meta Gene 2021;29:100932. [DOI: 10.1016/j.mgene.2021.100932] [Reference Citation Analysis]
21 Sim MA, Seet E, Khanna AK, Weingarten TN, Liew L, Law LS, Liu KE, Di Piazza F, Ti LK; PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY) Group Investigators. Association Between Race and Opioid-Induced Respiratory Depression: An International Post Hoc Analysis of the Prediction of Opioid-induced Respiratory Depression In Patients Monitored by Capnography Trial. Anesth Analg 2022. [PMID: 35350054 DOI: 10.1213/ANE.0000000000006006] [Reference Citation Analysis]
22 Di Mizio G, Marcianò G, Palleria C, Muraca L, Rania V, Roberti R, Spaziano G, Piscopo A, Ciconte V, Di Nunno N, Esposito M, Viola P, Pisani D, De Sarro G, Raffi M, Piras A, Chiarella G, Gallelli L. Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications. Int J Environ Res Public Health 2021;18:12936. [PMID: 34948545 DOI: 10.3390/ijerph182412936] [Reference Citation Analysis]
23 Kaehler M, Cascorbi I. Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia. Front Pharmacol 2021;12:696960. [PMID: 34262462 DOI: 10.3389/fphar.2021.696960] [Reference Citation Analysis]